Cite Filings / NRSN / 0001213900-24-030439
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
20-F

Annual and Transition Report of Foreign Private Issuers

NeuroSense Therapeutics Ltd. · Filed 2024-04-04 · Acc 0001213900-24-030439

Documents 1

  • 20-F Annual and Transition Report of Foreign Private Issuers , ea0202964-20f_neuro.htm

Around this filing

  • 2025-04-07 20-F Annual and Transition Report of Foreign Private Issuers
  • 2024-04-08 EFFECT Notice of Effectiveness
  • 2024-04-05 6-K Report of Foreign Issuer
  • 2024-04-04 POS AM Post-effective Amendment for Registration Statement
  • 2024-04-04 POS AM Post-effective Amendment for Registration Statement
  • 2024-04-04 20-F Annual and Transition Report of Foreign Private Issuers
  • 2023-03-22 20-F Annual and Transition Report of Foreign Private Issuers

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading ea0202964-20f_neuro.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…